Free Cash Flow

At SEMICON Korea, Axcelis launches its Purion H6, a critical tool for manufacturing the advanced semiconductors that will define the rapidly expanding AI era.

Aramark has increased its quarterly dividend, a move reflecting strong financials. But what does it say about its strategy in a changing global market?

CDW announces a $0.630 quarterly dividend, marking 12 straight years of increases. Discover how its robust capital strategy fuels consistent investor returns.

Automotive seating giant Adient boosts its 2026 forecast, banking on strong North American production and operational gains, despite a reported net loss.

Registration is open for Asia's massive food trade fair, where 180,000+ pros will discover the future of food and forge new global partnerships.

Whitecap Resources adds financial heavyweight Scott Althen to its board as Craig Bryksa departs, signaling a new phase of governance after its massive Veren merger.

A top Marine Corps general's visit to Ingalls Shipbuilding spotlights new amphibious warships vital for U.S. strategy and the massive economic engine behind them.

Memphis-based Barr Brands marks 80 years of innovation and 30 years as a 100% employee-owned company, a model for longevity and shared success.

Precision medicine firm Atropos Health joins NY's elite digital health startups, signaling a market shift toward scalable, data-driven healthcare solutions.

As PHINIA preps for its NYSE Investor Day, it plans to prove its value by balancing legacy engine tech with bold investments in a lower-carbon future.

Following a new White House mandate, Voyager Technologies is building the core infrastructure for a permanent lunar base, blending commerce and national security.

Estrella Immunopharma unveils promising Phase 1 data for its next-gen T-cell therapy, but can it overcome a crowded market and its own financial hurdles?

Colonial Heights schools adopt AI gun detection to boost safety, but the tech faces scrutiny over its real-world effectiveness and privacy implications.

After a brutal winter storm cut Bitcoin production, Cango Inc. is selling its crypto reserves to fund a strategic expansion into the booming AI market.

A next-gen immunotherapy enters trials, hoping its safer design can unlock the immune system and form a potent combo against advanced solid tumors.

McCain Foods launches its third 'Farm of the Future' in the UK, showcasing major strides in regenerative agriculture and setting ambitious 2030 climate goals.

In a decisive advisory vote, Allied Gaming shareholders endorsed the board's use of a 'poison pill' against a potential hostile takeover attempt.

CEO Andy Silvernail will detail the packaging giant's split and future strategy amid mixed earnings, setting high stakes for his upcoming investor address.

With a major Phase 3 trial now in Europe, Crystalys Therapeutics aims to fill a critical gap in gout care with a drug already proven in Asian markets.

A cancer researcher's 2,115% gain and a Hong Kong trader's 1,499% two-year run redefine market outperformance in the 2025 Investing Championship.